Animal research displays promise in treating AD.

Animal research displays promise in treating AD, brain heart and damage problems caused by SCIs New pet studies provide additional support for investigating stem cell treatments for Parkinson's disease, head trauma, and dangerous heart disease that accompany spinal cord injury, today according to analyze findings released . The work, presented at Neuroscience 2012, the annual getting together with of the Society for Neuroscience and the world's largest way to obtain emerging news about human brain science and health, shows scientists making progress toward using stem cell therapies to repair neurological damage.

Related StoriesBlocking the production of CHD4 protein may help increase performance of AML treatmentsResearchers determine new way to help AML individuals avoid a relapseYK-4-279 compound works against some forms of leukemia: Study In earlier in vitro research using four AML cell lines and individual AML cells, Angiocidin demonstrated the capability to stimulate maturation in the affected white cells, causing them to behave and function like normal cells. With 50 % achievement in the in vitro patient studies, the researchers following focused on how Angiocidin would carry out against cells from AML sufferers in vivo. Samples from an individual were injected right into a special mouse model produced by Martin Carroll, associate professor of medicine at the University of Pennsylvania.